Nagaileben Co., Ltd. (JP:7447)
:7447
Top Page
Nagaileben Co., Ltd.
(7447)
Select Model
Select Model
Rating:71Outperform
Price Target:
¥2,031.00
▲(12.21% Upside)
Action:ReiteratedDate:12/30/25
Score is driven primarily by strong financial resilience (debt-free balance sheet) and still-solid profitability, partially offset by weakening revenue momentum and inconsistent cash-flow conversion. Technical signals are soft/neutral, while valuation is supported by a high dividend yield but constrained by a mid-to-higher P/E.
Positive Factors
Debt-free balance sheet
Zero leverage and a large equity base provide durable financial flexibility, lowering solvency risk and enabling the company to fund working capital, modest capex, dividends, or opportunistic M&A without refinancing pressure. This conservatism supports resilience across cycles.
Negative Factors
Weakening revenue momentum
A falling top line signals potential demand erosion, market-share pressure, or pricing weakness. Over months this constrains reinvestment, margin maintenance, and earnings growth potential, making it harder to sustain dividend levels or expand product lines without reversing revenue trends.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero leverage and a large equity base provide durable financial flexibility, lowering solvency risk and enabling the company to fund working capital, modest capex, dividends, or opportunistic M&A without refinancing pressure. This conservatism supports resilience across cycles.
Read all positive factors
Nagaileben Co., Ltd. (7447) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥52.60B
Dividend Yield5.17%
Average Volume (3M)84.53K
Price to Earnings (P/E)19.7
Beta (1Y)0.65
Revenue Growth3.48%
EPS Growth-6.35%
CountryJP
Employees500
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Manufacturers
Share Statistics
EPS (TTM)23.11
Shares Outstanding30,736,000
10 Day Avg. Volume86,860
30 Day Avg. Volume84,533
Financial Highlights & Ratios
PEG Ratio-3.92
Price to Book (P/B)1.52
Price to Sales (P/S)3.70
P/FCF Ratio33.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)92.3
Revenue Forecast (FY)¥17.80B
Nagaileben Co., Ltd. Business Overview & Revenue Model
Company Description
Nagaileben Co., Ltd. is a Japanese company primarily engaged in the manufacturing and sale of medical and healthcare wear. The company produces uniforms and clothing items for healthcare professionals, including doctors, nurses, and other medical ...
How the Company Makes Money
Nagaileben Co., Ltd. generates revenue through the design, manufacture, and sale of healthcare and medical wear. Its key revenue streams include direct sales to hospitals, clinics, and other medical institutions, as well as partnerships with distr...
Nagaileben Co., Ltd. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
92
Very Positive
Cash Flow
63
Positive
| Breakdown | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.98B | 16.41B | 17.18B | 17.75B | 17.56B |
| Gross Profit | 6.57B | 6.90B | 7.41B | 7.72B | 7.87B |
| EBITDA | 3.86B | 4.27B | 4.88B | 5.31B | 5.53B |
| Net Income | 2.57B | 2.82B | 3.23B | 3.78B | 3.65B |
Balance Sheet | |||||
| Total Assets | 44.77B | 46.76B | 47.41B | 47.40B | 46.63B |
| Cash, Cash Equivalents and Short-Term Investments | 24.25B | 26.35B | 27.16B | 28.56B | 27.88B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 3.45B | 4.06B | 4.19B | 5.14B | 4.60B |
| Stockholders Equity | 41.32B | 42.70B | 43.21B | 42.26B | 42.03B |
Cash Flow | |||||
| Free Cash Flow | 1.89B | 2.14B | 1.55B | 3.35B | 4.21B |
| Operating Cash Flow | 2.18B | 2.29B | 1.81B | 3.44B | 4.45B |
| Investing Cash Flow | 1.11B | -1.77B | 3.42B | -471.43M | -3.26B |
| Financing Cash Flow | -3.89B | -2.93B | -2.94B | -3.20B | -1.97B |
Nagaileben Co., Ltd. Technical Analysis
Neutral
1810.00
Price Trends
1748.26
Positive
1805.85
Negative
1896.44
Negative
Market Momentum
-6.84
Negative
57.42
Neutral
83.31
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7447, the sentiment is Neutral. The current price of 1810 is above the 20-day moving average (MA) of 1704.45, above the 50-day MA of 1748.26, and below the 200-day MA of 1896.44, indicating a neutral trend. The MACD of -6.84 indicates Negative momentum. The RSI at 57.42 is Neutral, neither overbought nor oversold. The STOCH value of 83.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7447.
Nagaileben Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥128.62B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
78 Outperform | ¥173.56B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
76 Outperform | ¥29.61B | 14.12 | ― | 3.23% | 6.98% | -42.05% | |
74 Outperform | ¥116.53B | 13.53 | ― | 2.66% | 7.56% | -17.12% | |
71 Outperform | ¥52.60B | 19.69 | ― | 5.17% | 3.48% | -6.35% | |
66 Neutral | ¥116.91B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
* Consumer Cyclical Sector Average
JP:7447
Nagaileben Co., Ltd.
1,756.00
-133.33
-7.06%
JP:3002
Gunze
3,945.00
1,580.70
66.86%
JP:3569
Seiren Co
3,235.00
1,067.99
49.28%
JP:3104
Fujibo Holdings, Inc.
3,805.00
2,326.73
157.39%
JP:3201
Japan Wool Textile Co., Ltd.
1,897.00
525.16
38.28%
JP:3580
KOMATSU MATERE Co., Ltd.
774.00
32.59
4.40%
Nagaileben Co., Ltd. Corporate Events
Nagaileben Completes Treasury Share Disposal for Director Restricted Stock Compensation
Jan 9, 2026
Nagaileben Co., Ltd. has completed the payment procedures for a previously approved disposal of treasury shares to be used as restricted share-based remuneration for its directors, implementing a resolution passed by its Board of Directors on Dece...
Nagaileben Nearly Maxes Out ¥1 Billion Share Buyback Authorization
Dec 26, 2025
Nagaileben Co., Ltd. has completed a share repurchase program authorized by its board of directors on November 12, 2025, under provisions of the Companies Act, acquiring 387,500 of its own common shares via market purchases on the Tokyo Stock Exch...
Nagaileben Posts Weaker Q1 but Keeps Outlook for FY2026 Growth and Normalized Dividend
Dec 25, 2025
For the three months ended November 30, 2025, Nagaileben reported a 9.0% year-on-year decline in net sales to ¥2,920 million and a sharper drop in profitability, with operating profit down 28.8% to ¥412 million and profit attributable to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.